Patient Suitability Semaglutide is suitable for adults with type 2 diabetes or those struggling with obesity
Based on the form of administration and the ingredients, the cross-agency Expert Panel for Delimitation Questions (FOPH, FSVO, the Association of Cantonal Pharmacists [KAV], the Association of Swiss Cantonal Chemists [VKCS] and Swissmedic) classifies "Lemon Bottle" lipolysis solution as a medicinal product
100% of patients in the highest dose group lost at least 5% of their starting weight, and approximately 75% lost more than 15%
Semaglutide for Managing Overweight and Obesity Q&A Being a chronic, relapsing disease with a high prevalence, obesity needs long-term therapy
Additionally, the Wegovy 7.2mg higher-dose injectable is now available as of 2026
It is essential to balance the potential benefits of these medications with their risks, ensuring that individuals receive the most effective and safe treatment for their unique needs